Literature DB >> 27221316

Acute Autonomic Engagement Assessed by Heart Rate Dynamics During Vagus Nerve Stimulation in Patients With Heart Failure in the ANTHEM-HF Trial.

Bruce D Nearing1, Imad Libbus2, Badri Amurthur2, Bruce H Kenknight2, Richard L Verrier3.   

Abstract

BACKGROUND: Chronic vagus nerve stimulation (VNS) applied to produce biomimetic levels of parasympathetic activation is feasible, well tolerated, safe, improves left ventricular ejection fraction, NYHA class, heart rate variability, and baroreflex function, and reduces T-wave alternans (TWA) in patients with chronic heart failure. However, the acute effects of VNS on beat-to-beat heart rate dynamics have not been systematically characterized in humans. METHODS AND
RESULTS: We evaluated acute effects of VNS on R-R-interval dynamics during the VNS titration period in patients (n = 59) enrolled in ANTHEM-HF trial by quantifying effects during continuous cyclic VNS (14-seconds on-time, 66-seconds off-time) adjusted to the maximum tolerable dose without excessive (<4 bpm) bradycardia during the 10-week titration period. VNS elicited an immediate change in heart rate that was correlated to VNS current amplitude, pulse width, and frequency. Heart rate decreased more in the 28 patients with right-sided stimulation (-2.22 ± 0.13 bpm) than in the 31 patients with left-sided stimulation (-0.60 ± 0.08 bpm, P < 0.001). The linear correlation between stimulus intensity and lengthening of the R-R interval was stronger among the 28 patients with right-sided VNS implantation (r = 0.88, P < 0.0001) than among the 31 patients with left-sided VNS implantation (r = 0.49, P < 0.002). In all patients, the heart rate change elicited by VNS was significantly greater than the change during the same timing intervals in 10 randomly selected patients without stimulation (+0.08 ± 0.06 bpm, P < 0.001).
CONCLUSION: Instantaneous heart rate change during therapeutic levels of VNS in patients with heart failure indicates consistent modulation of the autonomic nervous system for both left- and right-sided stimulation.
© 2016 The Authors. Journal of Cardiovascular Electrophysiology published by Wiley Periodicals, Inc.

Entities:  

Keywords:  ANTHEM-HF trial; autonomic regulation therapy; heart failure; heart rate; vagus nerve stimulation

Mesh:

Year:  2016        PMID: 27221316     DOI: 10.1111/jce.13017

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  13 in total

1.  Cervical vagus nerve stimulation augments spontaneous discharge in second- and higher-order sensory neurons in the rat nucleus of the solitary tract.

Authors:  Eric Beaumont; Regenia P Campbell; Michael C Andresen; Stephanie Scofield; Krishna Singh; Imad Libbus; Bruce H KenKnight; Logan Snyder; Nathan Cantrell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-05-05       Impact factor: 4.733

2.  Implantable vagus nerve stimulation system performance is not affected by internal or external defibrillation shocks.

Authors:  Imad Libbus; Scott R Stubbs; Scott T Mazar; Scott Mindrebo; Bruce H KenKnight; Lorenzo A DiCarlo
Journal:  J Interv Card Electrophysiol       Date:  2021-08-31       Impact factor: 1.759

3.  Baseline NT-proBNP and responsiveness to autonomic regulation therapy in patients with heart failure and reduced ejection fraction.

Authors:  Inder Anand; Jeffrey L Ardell; Doug Gregory; Imad Libbus; Lorenzo DiCarlo; Rajendra K Premchand; Kamal Sharma; Sanjay Mittal; Rufino Monteiro
Journal:  Int J Cardiol Heart Vasc       Date:  2020-05-30

4.  Background pharmacological therapy in the ANTHEM-HF: comparison to contemporary trials of novel heart failure therapies.

Authors:  Rajendra K Premchand; Kamal Sharma; Sanjay Mittal; Rufino Monteiro; Imad Libbus; Jeffrey L Ardell; Douglas D Gregory; Bruce H KenKnight; Badri Amurthur; Lorenzo A DiCarlo; Inder S Anand
Journal:  ESC Heart Fail       Date:  2019-07-24

5.  Comparison of symptomatic and functional responses to vagus nerve stimulation in ANTHEM-HF, INOVATE-HF, and NECTAR-HF.

Authors:  Inder S Anand; Marvin A Konstam; Helmut U Klein; Douglas L Mann; Jeffrey L Ardell; Douglas D Gregory; Joseph M Massaro; Imad Libbus; Lorenzo A DiCarlo; John James E Udelson; Javed Butler; John D Parker; John R Teerlink
Journal:  ESC Heart Fail       Date:  2020-01-27

6.  Therapeutic responsiveness to vagus nerve stimulation in patients receiving beta-blockade for heart failure with reduced ejection fraction.

Authors:  Enea Dede; Douglas D Gregory; Jeffrey L Ardell; Imad Libbus; Lorenzo A DiCarlo; Rajendra K Premchand; Kamal Sharma; Sanjay Mittal; Rufino Monteiro; Inder S Anand; Hans-Dirk Düngen
Journal:  Int J Cardiol Heart Vasc       Date:  2021-10-20

Review 7.  Vagal stimulation in heart failure.

Authors:  Veronica Dusi; Gaetano Maria De Ferrari
Journal:  Herz       Date:  2021-10-30       Impact factor: 1.443

8.  Persistent Autonomic Engagement and Cardiac Control After Four or More Years of Autonomic Regulation Therapy Using Vagus Nerve Stimulation.

Authors:  Imad Libbus; Rajendra K Premchand; Kamal Sharma; Sanjay Mittal; Rufino Monteiro; Badri Amurthur; Bruce H KenKnight; Lorenzo A DiCarlo; Inder S Anand
Journal:  Front Physiol       Date:  2022-03-11       Impact factor: 4.566

Review 9.  Vagus Nerve Stimulation and the Cardiovascular System.

Authors:  Michael J Capilupi; Samantha M Kerath; Lance B Becker
Journal:  Cold Spring Harb Perspect Med       Date:  2020-02-03       Impact factor: 6.915

10.  Shoulder transcutaneous electric nerve stimulation decreases heart rate via potentiating vagal tone.

Authors:  Chun-Ming Hsieh; Hsien-Yu Peng; Wan-Chen Lin; Huang-Chung Chen; Yu-Cheng Ho; Chi-Jui Li; Xi-Guan Wu; Jen-Yi Chung; Shin-Da Lee; Tzer-Bin Lin
Journal:  Sci Rep       Date:  2021-09-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.